RNA interference strategies as therapy for respiratory viral infections

Pediatric Infectious Disease Journal

Volumn 27, Issue SUPPL. 10, 2008, Pages

  DeVincenzo, John P ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Antiviral; Respiratory viruses; RNA interference; RNAi; SiRNA; Therapy

Indexed keywords

ANTIVIRUS AGENT; SMALL INTERFERING RNA;

ARTICLE; CHEMISTRY; HUMAN; INFLUENZA; INFLUENZA VIRUS A; LUNG; PATHOLOGY; RESPIRATORY TRACT INFECTION; RNA INTERFERENCE; VIROLOGY; VIRUS INFECTION;

ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRUS DISEASES;

EID: 56149108528     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318168b759     Document Type: Conference Paper

References (18)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391:806-811. (Pubitemid 28099681)
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-498. (Pubitemid 32494397)
3. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature. 2001;413:732-738. (Pubitemid 33009951)
4. Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dentritic cells through TLR7. Nat Med. 2005;11:263-270. (Pubitemid 40460553)
5. Schlee M, Hornung V, Hartmann G. siRNA and isRNA: two edges of one sword. Mol Ther. 2006;14:463-469.
6. de Fougerolles A, Vornlocher H, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov. 2007;6:443-453. (Pubitemid 47064567)
7. Johnson JE, Gonzales RA, Olson SJ, Wright PF, Graham BS. The histopathology of fatal untreated human respiratory syncytial virus infection. Mod Pathol. 2007;20:108-119. (Pubitemid 44967956)
8. Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology. J Virol. 2002;76:5654-5666. (Pubitemid 34517916)
9. DeVincenzo JP. Respiratory syncytial virus infections in hematopoietic stem cell transplant recipients and other severely immunocompromised patients. Pediatr Pathol Mol Med. 2000;19:115-132.
10. Zhang X, Shan P, Jiang D, et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia reperfusion induced lung apoptosis. J Biol Chem. 2004;279:10677-10684. (Pubitemid 38372680)
11. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med. 2005;11:50-55. (Pubitemid 40215837)
12. American Academy of Pediatrics CoID. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. Pediatrics. 1996;97:137-140.
13. DeVincenzo JP. Therapy of respiratory syncytial virus infection. Pediatr Infect Dis. 2000;19:786-790.
14. Kimpen JL, Schaad UB. Treatment of respiratory syncytial virus bronchiolitis: 1995 poll of members of the European Society for Paediatric Infectious Diseases. Pediatr Infect Dis J. 1997;16:479-481. (Pubitemid 27212783)
15. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531-537.
16. American Academy of Pediatrics CoIDaCoFaN. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1442-1446.
17. Meyers RE, Alvarez R, Tripp R, et al. ALN-RSV01, an RNAi therapeutic for the treatment of respiratory syncytial virus (RSV) infection. E-Pediatr Acad Soc. 2007:616295.12.
18. DeVincenzo JP, Cehelsky J, Foote K, et al. Early clinical evaluation of an RNA interference (RNAi) based therapy for respiratory syncytial virus (RSV) infection. E-Pediatr Acad Soc. 2007:616295.7.